All Stories

  1. Plasma Chitotriosidase Activity and Arteriogenic Erectile Dysfunction.
  2. Sildenafil in treating impotence in patients with combat-related post-traumatic stress disorder.
  3. Fbrinogen concentrate on perioperative bleeding in transurethral resection of the prostate
  4. Supradiaphragmatic Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass (CPB).
  5. High success rate with new modified endoscopic treatment for high-grade VUR: A pilot study with preliminary report
  6. The effect of parenteral testosterone administration prior to hypospadias surgery.
  7. The efficacy and safety of pentoxifylline in early chronic Peyronie's disease.
  8. Psychometric properties of the Female Sexual Distress Scale-Revised in women.
  9. Tramadol for treatment of urinary frequency (frequent urination).
  10. Association of genetic polymorphism of glutathione S-transferase with bladder cancer.
  11. Effects of the polymorphisms of the endothelial nitric oxide synthase gene on prostate cancer.
  12. Comparison of macroscopic one-layer over number 1 nylon suture vasovasostomy with the standard two-layer microsurgical procedure
  13. Sexual Function after Non-Nerve-Sparing Radical Cystoprostatectomy: A Comparison between Ileal Conduit Urinary Diversion and Orthotopic Ileal Neobladder Substitution
  14. Association between polymorphisms in osteopontin gene and calcium oxalate kidney stones.
  15. Polymorphisms in Aryl Hydrocarbon Receptor Gene Are Associated With Idiopathic Male Factor Infertility
  16. The effects of opiate consumption on serum reproductive hormone and sperm parameters.
  17. Reply to Letter to the Editor
  18. G-protein β3 subunit gene 825C/T polymorphism and its association with impotence.
  19. Opium consumption is negatively associated with serum prostate-specific antigen (PSA).
  20. Quality of life after radical cystectomy for bladder cancer in men.
  21. The influence of promoter -202 A/C polymorphism of the IGFBP-3 gene on impotence.
  22. Effects of EPA, γ-linolenic acid or coenzyme Q10 on serum prostate-specific antigen levels.
  23. Penile vascular indices in surgically treated and conservatively treated penile fracture.
  24. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in infertile men.
  25. Quality of life and sexual functioning in young women with breast cancer 1 year after lumpectomy.
  26. G Protein β3 subunit gene C825T polymorphism and its association with prostate cancer.
  27. Influence of opioid consumption on serum prostate-specific antigen levels.
  28. The roles of omega-3 and omega-6 fatty acids in idiopathic male infertility.
  29. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms: association with kidney cancer.
  30. Estrogen receptors alpha polymorphism in prostate cancer.
  31. The effect of coenzyme Q₁₀ supplementation on partner pregnancy rate in infertile men.
  32. Relationship of insulin-like growth factor gene polymorphism with prostate cancer.
  33. The association between bladder cancer and polymorphism in the insulin-like growth factor gene.
  34. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are linked with kidney cancer.
  35. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer.
  36. Association of the polymorphisms in the sex hormone-binding globulin (SHBG) gene with infertility.
  37. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile.
  38. Evaluating the role of the FSH receptor gene Thr307-Ala and Asn680-Ser polymorphisms in infertility.
  39. Relationship between premature ejaculation and polymorphisms of the dopamine transporter gene.
  40. Opium consumption and risk of bladder cancer: A case-control analysis.
  41. Genetic susceptibility of methylenetetrahydrofolate polymorphisms with risk for bladder cancer.
  42. Relationship between genetic polymorphisms of methylenetetrahydrofolate and infertility.
  43. Association of the polymorphisms of the endothelial nitric oxide synthase gene with impotence.
  44. Association of polymorphisms in the estrogen receptors with the semen parameters.
  45. A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia
  46. Effect of pentoxifylline on semen parameters and reproductive hormones.
  47. Safety and efficacy of sildenafil in the treatment of Parkinson-emergent impotence.
  48. The efficacy and safety of bupropion for treating low libido in ovulating women.
  49. The effects of the adjunctive bupropion on male sexual dysfunction induced by a SSRIs.
  50. Coenzyme Q10 supplementation in early chronic Peyronie's disease.
  51. Role of methylenetetrahydrofolate reductase gene polymorphisms in the development of impotence.
  52. The role of endothelial nitric oxide synthase (eNOS) T-786C, G894T gene in the risk of infertility.
  53. Relationship between polymorphisms of methylenetetrahydrofolate reducta gene and prostate cancer.
  54. Efficacy and safety of sildenafil citrate and saffron (Crocus sativus Linn.) for treating impotence.
  55. The association of glutathione-S-transferase gene polymorphisms male infertility.
  56. Reproductive hormones in women with homozygous beta-thalassemia major.
  57. Relationship of omega-3 and omega-6 fatty acids with semen characteristics.
  58. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in women.
  59. Evaluation of semen variables in patients with chronic hepatitis C.
  60. Analysis of association between the 5-HTTLPR and STin2 polymorphisms with premature ejaculation.
  61. Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer.
  62. Sperm Chromatin Structure Assay Analysis of Iranian Mustard Gas Casualties: A Long-Term Outlook
  63. Utility of PSA Density and Free to Total PSA Ratio for Detecting Prostate Cancer.
  64. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with impotence.
  65. A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s disease
  66. New method for connecting ureter into the bladder in kidney transplantation.
  67. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study
  68. Efficacy of coenzyme Q10 on semen parameters and reproductive hormones in infertile men.
  69. Efficacy and Safety of Omega-3 for Treatment of Early-Stage Peyronie’s Disease.
  70. Polymorphisms of the serotonin transporter gene and their relation to premature ejaculation.
  71. The effect of the mode of delivery on the quality of life, sexual function, and sexual satisfaction.
  72. Midodrine for the treatment of organic absence of ejaculation but not spinal cord injury.
  73. Treatment of nonparaphilic hypersexuality in men analog of gonadotropin-releasing hormone.
  74. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men.
  76. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men MS.
  77. The effects of intensive, long-term treadmill running on sex hormones.
  78. Sperm DNA damage and semen quality impairment after treatment with SSRI.
  79. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in MS.
  80. Reply: Dapoxetine in Premature Ejaculation
  81. Evaluation of Endocrine Profile and Hypothalamic-Pituitary-Testis Axis in Selective Serotonin Reuptake Inhibitor-Induced Male Sexual Dysfunction
  82. Prevalence of the overactive bladder among Iranian women based on the International Continence Society definition: a population-based study
  83. Evaluation of semen quality in male patients with homozygous beta-thalassemia major.
  84. Infertility prevalence in Iran.
  85. Premature Ejaculation and Pharmaceutical Company-Based Medicine: The Dapoxetine Case
  86. RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study
  87. Salvage of Sildenafil Failures With Bremelanotide: A Randomized, Double-Blind, Placebo Controlled Study
  88. Prevalence of benign prostatic hyperplasia in men 40 years old or older.
  89. Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation
  90. Safety and efficacy of venlafaxine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomised study
  91. Prevalence of nocturnal enuresis, among school children.
  92. Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Study
  93. Safety and efficacy of escitalopram in the treatment of premature ejaculation.
  94. Dapoxetine for treatment of premature ejaculation.
  95. Incidental prostatic adenocarcinoma in after prostate and bladder removal.
  96. Prevalence of adult urinary stone in a population-based study in Iran.
  97. Screening for prostate cancer to determine its prevalence.
  98. Comparison of dapoxetine versus paroxetine for treatment of premature ejaculation.
  99. Population-based screening for prostate cancer.
  100. Salvage of sildenafil failures with cabergoline: in impotence.
  101. Urtica Dioica for treatment of prostate enlargement.
  102. Tamsulosin for treatment of painful ejaculation.
  103. Retracted:Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: a double-blind, placebo-controlled, randomized study
  104. Tramadol for treatment of premature ejaculation.
  105. Prevalence of female sexual dysfunction.
  106. Citalopram for treatment of premature ejaculation.
  107. Combination chemotherapy with docetaxel, estramustine and suramin for prostate cancer.
  108. Oral sildenafil in the treatment of erectile dysfunction in diabetic men:.
  109. Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study
  110. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran.
  111. Antisperm antibodies in hydroceles before and after surgery.
  112. Endocrine profiles and semen quality in spinal cord injured men
  113. Stonr fragmentation of renal calculi during early pregnancy.
  114. Level of injury and hormone profiles in spinal cord-injured men
  115. Testicular effect of mustard gas.
  116. Therapeutic effects of high-dose isoxsuprine in the management of mixed-type impotence.
  117. Eye injuries caused by mustard gas: diagnosis, treatment, and medical defense.
  118. Ureterovaginal fistula after vaginal delivery
  120. Residual urine measurement in men: comparison between real-time ultrasonography and catheterization.
  121. Penile fractures: evaluation, therapeutic approaches and long-term results.